Design Expert-Implemented Nimodipine-Loaded Lyophilized Nanoemulsifying Drug Delivery System for Improved Oral Bioavailability and Physical Stability

ABSTRACT

Purpose:To improve the oral bioavailability as well as the physical stability of nimodipine, Design-Expert-driven nimodipine loaded nanoemulsifying drug delivery system was developed with a certain quality target product profile. Materials and Methods: In this investigation, the three components triacetin as oil phase, labrasol as a surfactant, and plurol oleique CC 497 as co-surfactant were selected after screening. The ratio of surfactant and co-surfactant (Smix) was selected from the pseudo-ternary phase diagram drawn by using ProSim ternary software. A d-optimal mixture design was employed to optimize the formulation. The dynamic light scattering, Fourier transform Infrared, Differential Scanning Calorimetry, X-ray Diffraction, Scanning Electron Microscopy, in vitro drug release, stability study, andin vivo pharmacokinetic studies were carried out for the characterization of the optimized formulation. Results: The globule size, PDI, and Zeta potential of the optimized formulation were found to be 322.1 nm, 0.48, and -14.5 mV respectively. The result of in vivo pharmacokinetic studies exhibited three-fold enhanced oral bioavailability of the optimized nanoemulsion as compared to the pure drug of nimodipine and the physical stability of the optimized nanoemulsion improved significantly as compared to the pure drug. Conclusion: The NIMO-loaded nanoemulsifying drug delivery system can be successfully fabricated by implementing the Design-Expert with improved oral bioavailability and physical stability significantly as compared to the pure drug of NIMO.

KEYWORDS

• Bioavailability
• Physical stability
• Pseudo ternary phase diagram
• Design-Expert
• Lyophilized
• Nanoemulsifying drug delivery system

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.58.1s.12Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 58, ISSUE 1SSynthesis and Bioactive Investigation of Amino Acids Fused 1,3,4-Oxadiazole Derivatives as Unnatural Amino AcidsAjay Singh Bisht, Divya Juyal · pp. s67–s72Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 1SChemical and Pharmacological Assessment of Substituted 1,2,4-Triazole Fused Pyrimidines as Anti-microbial AgentPrafulla Sabale, Lata Potey, Suchita Waghmare, Nusrat Sayyad, Vidya Sabale · pp. s73–s79Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 1SSynthesis, Characterization, in silico and in vivo Evaluation of Amino Acid Derived Schiff Bases of Quinoline- Benzimidazole Hybrids as Anti-epileptic AgentsSonakshi Tyagi, Salahuddin Salahuddin, Avijit Mazumder, Rajnish Kumar, Vimal Datt, Km. Shabana, Abhishek Shankar Sharma, Mohamed Jawed Ahsan, Mohammad Shahar Yar · pp. s80–s92Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 1SQuinazolin-4-one Derivatives: Enoyl-acyl Carrier Protein (ACP) Reductase (InhA) Antagonists Using in silico Drug Design ApproachKavitha K, Mohan S, Jothikanth. V, Srinivasan N, Manojkumar S, Esakiprasanth. R, Bakitha Jessila M, Revathi P, Venkatesh V, Subash M · pp. s93–s102Original ArticleSame type: Article